Showing results (581-590 of 1,126) with videos related to
Sort By:
Pageof 113
Cancer Genetics|March 30, 2025
Mutation status in yes-associated protein 1 (YAP1) in an insulinoma cell line Rin-5FTakayoshi KibaCancer Genetics|May 28, 2025
HRD status variation in consecutive tumour biopsies in a pan-cancer cohort: a descriptive single-center study including patients from the Phase 1 Unit, Copenhagen University Hospital, RigshospitaletRosa Damkjær Britton, Daniela Alosi, Luca Robinson, et al.Cancer Genetics|June 17, 2025
Efficacy of pembrolizumab in MSI-high and BRCA-positive castration-resistant prostate cancerKeita Higa, Satoshi Yamamoto, Koichiro Kurokawa, et al.Cancer Genetics|June 12, 2025
Acute cardiac dysfunction in patients with ovarian cancer treated with Niraparib due to TFAM mutation: A case series and functional analysisFei Liu, Wen Liu, Danya Li, et al.Cancer Genetics|June 7, 2025
The Interplay of N6-Methyladenosine and Ferroptosis in Cancer: A Promising Therapeutic AvenueKirthik Roshan M, Rituparna Pal, Subhadra Kumari, et al.Cancer Genetics|January 22, 2026
Functional impact assessment of tissue-specific missense variants in the PTPRH gene using a multi-tool computational frameworkAli Ammar Naseem, Ranjha Khan, Uzma HameedCancer Genetics|July 9, 2013
CTLA-4 gene polymorphism at position +49 A>G in exon 1: a risk factor for cervical cancer in Indian womenPriyanka Gokhale, Shilpa Kerkar, Hemant Tongaonkar, et al.Cancer Genetics|January 15, 2013
Change in HER2 (ERBB2) gene status after taxane-based chemotherapy for breast cancer: polyploidization can lead to diagnostic pitfalls with potential impact for clinical managementAlexander Valent, Frédérique Penault-Llorca, Anne Cayre, et al.Cancer Genetics|January 15, 2013
Contribution of MLPA to routine diagnostic testing of recurrent genomic aberrations in chronic lymphocytic leukemiaLauren Véronèse, Olivier Tournilhac, Patricia Combes, et al.Cancer Genetics|December 19, 2012
Monosomal karyotype in acute myeloid leukemia defines a distinct subgroup within the adverse cytogenetic risk categoryGeorgia Voutiadou, George Papaioannou, Maria Gaitatzi, et al.Pageof 113